anonymous
Guest
anonymous
Guest
I’d give the new guys a chance to turn things around, it’s a great product with more indications coming.
I thought that during the call but then one of my Drs, big KOL told me yesterday psa data looks better than current data but this launch has been such a disaster for this dr and patients that this KOL and other docs agree ilumya is not worth the hassle and the medical benefit is a pain in the ass. Doc said it’s not worth the headache so whomever they put in place is going to be fighting a losing battle.